Theravance Biopharma (TBPH) EBITDA Margin Growth (1y) (2014 - 2026)
Theravance Biopharma (TBPH) EBITDA Margin Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Theravance Biopharma |
835.85 Mn |
441.18 Mn |
- |
3,471.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
3,471.00 |
| Dec 31, 2025 |
12,910.00 |
| Sep 30, 2025 |
9,315.00 |
| Jun 30, 2025 |
32,511.00 |
| Mar 31, 2025 |
-803.00 |
| Dec 31, 2024 |
-1,353.00 |
| Sep 30, 2024 |
-1,821.00 |
| Jun 30, 2024 |
43.00 |
| Mar 31, 2024 |
13,115.00 |
| Dec 31, 2023 |
8,347.00 |
| Sep 30, 2023 |
-741,794.00 |
| Jun 30, 2023 |
-4,196.00 |
| Mar 31, 2023 |
82,756.00 |
| Dec 31, 2022 |
25,680.00 |
| Sep 30, 2022 |
762,886.00 |
| Jun 30, 2022 |
33,159.00 |
| Mar 31, 2022 |
-47,987.00 |
| Dec 31, 2021 |
3,258.00 |
| Sep 30, 2021 |
13,667.00 |
| Jun 30, 2021 |
1,470.00 |
